IRDAI Releases 2026 Claim Settlement Ratios: Acko, Aditya Birla, Galaxy Lead; Shriram, IFFCO Tokio Slip Below 90%

The Insurance Regulatory and Development Authority of India (IRDAI) released the latest claim settlement ratio data for health and general insurers in February 2026, highlighting how efficiently insurers settled claims within 3 months during FY 2024-25.
Claim Settlement Ratio as a Performance Indicator
Claim settlement ratio reflects the percentage of claims settled by an insurer out of the total claims received in a given period. IRDAI data focuses on claims settled within 3 months, as timely settlement is a key indicator of operational efficiency in health and general insurance.
Performance of Public Sector General Insurers
Among public sector insurers, United India Insurance Co. Ltd. settled 95.26% of claims within 3 months. The New India Assurance Co. Ltd. and National Insurance Co. Ltd. reported ratios of 91.75% and 91.79% respectively, while The Oriental Insurance Co. Ltd. recorded 90.17%.
Read More: Bharti AXA Life Insurance Partners with Equitas Small Finance Bank for Bancassurance!
Private Sector General Insurers Overview
Acko General Insurance Ltd. reported a claim settlement ratio of 99.98% for FY 2024 25. Reliance General Insurance Co. Ltd. followed at 99.32%.
Insurers such as ICICI Lombard General Insurance Co. Ltd. and HDFC ERGO General Insurance Co. Ltd. recorded 98.45% and 98.85% respectively. Kshema General Insurance Co. Ltd. reported 26.88%, while IFFCO Tokio General Insurance Co. Ltd. stood at 85.27%.
Standalone Health Insurers Claim Data
Standalone health insurers showed high settlement levels. Aditya Birla Health Insurance Co. Ltd., Galaxy Health Insurance Co. Ltd., Narayana Health Insurance Co. Ltd., and Niva Bupa Health Insurance Co. Ltd. each reported 100% claims settled within 3 months. The overall settlement ratio for standalone health insurers was 99.93%.
Conclusion
The IRDAI claim settlement data for FY 2024 25 provides a snapshot of how health and general insurers handled claims within stipulated timelines. The figures indicate varying settlement efficiency across public, private, and standalone health insurers.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 5, 2026, 11:37 AM IST

Team Angel One
- Adani Defence Signs Five-Year Ammunition Supply Agreement for AK-203 Programme
- AstraZeneca Gains FDA Approval for Camizestrant Combo in ESR1-Mutated Advanced Breast Cancer
- CBI Files FIR Against Subhash Chandra Over LIC Housing Finance Loan Fraud Allegations
- Top Gainers and Losers on September 3, 2026: Adani Ports, Axis Bank and HDFC Bank Rise Up to 2%
- Hilton Expands India Presence With 60 Hotels Under Construction, Plans 400 More Properties


